Glycophos

Medicinal product

(Invented) name

Glycophos

Active substance (s)

Natrio glicerofosfatas

Strength

216 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B05XA14, Sodium glycerophosphate

Marketing authorisation holder

Fresenius Kabi AB, Švedija

Date of authorisation

2002-12-20

Date of renewal

2012-04-23

Documents

2906 Glycophos II PL 2024 03 01.docx

2906 Pakuotės lapelis 2024 03 01.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 ml koncentrato yra	1 ml
Natrio glicerofosfatas	216 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
6033	11187	1011187	flakonas	20 ml N10		Receptinis	LT/1/02/2906/001	Netiekiama	-	-	No	-	-
100786	86896	1086896	ampulė	20 ml N20		Receptinis	LT/1/02/2906/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2012-04-23	Perregistruotas
2002-12-20	Registruotas